1. Home
  2. RGS vs CLNN Comparison

RGS vs CLNN Comparison

Compare RGS & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regis Corporation

RGS

Regis Corporation

HOLD

Current Price

$27.91

Market Cap

72.7M

ML Signal

HOLD

Logo Clene Inc.

CLNN

Clene Inc.

HOLD

Current Price

$5.05

Market Cap

79.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGS
CLNN
Founded
1922
2012
Country
United States
United States
Employees
N/A
79
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.7M
79.1M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
RGS
CLNN
Price
$27.91
$5.05
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$33.75
AVG Volume (30 Days)
5.1K
51.1K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
20.24
N/A
EPS
0.89
N/A
Revenue
$210,134,000.00
N/A
Revenue This Year
N/A
$17.64
Revenue Next Year
N/A
$19,516.77
P/E Ratio
$30.61
N/A
Revenue Growth
3.52
N/A
52 Week Low
$18.23
$3.30
52 Week High
$31.50
$13.50

Technical Indicators

Market Signals
Indicator
RGS
CLNN
Relative Strength Index (RSI) 42.36 32.26
Support Level $25.95 $4.48
Resistance Level $28.44 $6.61
Average True Range (ATR) 0.85 0.34
MACD -0.20 -0.09
Stochastic Oscillator 0.25 2.27

Price Performance

Historical Comparison
RGS
CLNN

About RGS Regis Corporation

Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Share on Social Networks: